bone densitometry, quantitative ultrasound, osteoporosis, population studies, vertebral fracture

Size: px
Start display at page:

Download "bone densitometry, quantitative ultrasound, osteoporosis, population studies, vertebral fracture"

Transcription

1 JOURNAL OF BONE AND MINERAL RESEARCH Volume 19, Number 5, 2004 Published online on March 1, 2004; doi: /JBMR American Society for Bone and Mineral Research Association of Five Quantitative Ultrasound Devices and Bone Densitometry With Osteoporotic Vertebral Fractures in a Population-Based Sample: The OPUS Study Claus C Glüer, 1 Richard Eastell, 2 David M Reid, 3 Dieter Felsenberg, 4 Christian Roux, 5 Reinhard Barkmann, 1 Wolfram Timm, 1 Tilo Blenk, 4 Gabi Armbrecht, 4 Alison Stewart, 3 Jackie Clowes, 2 Friederike E Thomasius, 4 and Sami Kolta 5 ABSTRACT: We compared the performance of five QUS devices with DXA in a population-based sample of 2837 women. All QUS approaches discriminated women with and without osteoporotic vertebral fractures. QUS of the calcaneus performed as well as central DXA. Introduction: Quantitative ultrasound (QUS) methods have found widespread use for the assessment of bone status in osteoporosis, but their optimal use remains to be established. To determine QUS performance for current devices in direct comparison with central DXA, we initiated a large population-based investigation, the Osteoporosis and Ultrasound Study (OPUS). Materials and Methods: A total of 463 women years of age and 2374 women years of age were measured on five different QUS devices along with DXA of the spine and the proximal femur. Their vertebral fracture status was evaluated radiographically. The association of QUS and DXA with vertebral fracture status was evaluated using logistic regression. Results: All QUS approaches tested discriminated women with and without osteoporotic vertebral fractures (20% height reduction), with age-adjusted standardized odds ratios ranging for amplitude-dependent speed of sound (AD-SOS) at the finger phalanges, for broadband ultrasound attenuation (BUA) at the calcaneus, and for speed of sound (SOS) at the calcaneus, for DXA of the total femur, and for DXA at the spine. For more severe fractures (40% height reduction), age-adjusted standardized odds ratios increased to up to 1.9 for DXA of the spine and 2.3 for SOS of the calcaneus. Conclusions: In conclusion, all five QUS devices tested showed significant age-adjusted differences between subjects with and without vertebral fracture. When selecting the strongest variable, QUS of the calcaneus worked as well as central DXA for identification of women at high risk for prevalent osteoporotic vertebral fractures. QUS-based case-finding strategies would allow halving the number of radiographs in high-risk populations, and this strategy works increasingly well for women with more severe vertebral fractures. It is likely that the good performance of QUS was in part achieved by rigorous quality assurance measures that should also be used in clinical practice. J Bone Miner Res 2004;19: Published online on March 1, 2004; doi: /JBMR Key words: bone densitometry, quantitative ultrasound, osteoporosis, population studies, vertebral fracture Dr Barkmann serves as a consultant. Dr Eastell received research funding from IGEA. Dr Glüer served as a consultant for IGEA. Dr Reid received grants from Procter & Gamble and served as a consultant for Eli Lilly and Company, Procter & Gamble, Novartis, and Roche. All other authors have no conflict of interest. INTRODUCTION QUANTITATIVE ULTRASOUND (QUS) methods have found widespread use in the assessment of bone status in osteoporosis. (1 4) Lower cost and lack of ionizing radiation have facilitated dissemination and enhanced acceptance by patients and physicians. Prospective studies have demonstrated that risk of fracture of the proximal femur, (5 8) the vertebrae, (9 11) and other sites (10,12 16) can be predicted by QUS, with standardized risk ratios at least comparable with other peripheral measurement approaches, and in some studies, even similar to central bone densitometry methods. (6) Effective prevention programs for osteoporosis require quick, inexpensive diagnostic methods suited for widespread use. Validating QUS-based assessment of osteoporosis thus offers the opportunity to reduce the medical and economic burden of this debilitating disease, pro- 1 Medical Physics, Department of Diagnostic Radiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 2 University of Sheffield Clinical Sciences Centre, Sheffield, United Kingdom; 3 Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom; 4 Diagnostic Radiology, Free University Berlin, Berlin, Germany; 5 Centre d Evaluation des Maladies Osseuses, Service de Rhumatologie, Assistance-Publique, Hopitaux de Paris, René Descartes University, Paris, France. 782

2 ULTRASOUND, DENSITOMETRY, AND VERTEBRAL FRACTURES 783 vided that cost-effective strategies for identifying patients at high risk for fracture could be developed. (17,18) Despite its proven advantages, the use of QUS remains controversial. While it is undisputed that QUS methods can be used to assess fracture risk, it is unclear how they can be used for the diagnosis of osteoporosis and how patients who would benefit most from treatment could be selected based on QUS. Technological diversity among QUS approaches complicates the validation process. Many new devices have been introduced that differ from those machines used in the early prospective studies. Hence, it is not clear whether the current technologies meet or exceed performance standards of those early approaches. Monitoring performance has been inconsistent because of lower longitudinal sensitivity and the lack of validated quality assurance methods to control equipment stability. To gather the data required to address the issues raised above and to provide clear guidelines for appropriate clinical use of QUS methods, we initiated the Osteoporosis and Ultrasound (OPUS) study. The performance of QUS methods can only be judged if they are directly compared with the performance of competing diagnostic methods. Therefore, those diagnostic methods, for example, laboratory markers of bone turnover, genetic markers, X-ray based bone densitometry techniques, function performance tests, and clinical risk factor questionnaires, were also incorporated in the OPUS study protocol. The OPUS participants were selected from random population samples to collect reference data and to allow drawing conclusions regarding the use of QUS and the other methods in the general population or in defined subsets thereof. In this study, we report the baseline visit of OPUS. To assess the performance of QUS methods, we studied the association with prevalent vertebral fractures and compared it with bone densitometry. MATERIALS AND METHODS Recruitment Five European centers participated in the OPUS study: Aberdeen (Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK), Berlin (Diagnostische Radiologie, Klinikums Benjamin Franklin der Freien Universität Berlin, Berlin, Germany), Kiel (Medizinische Physik, Klinik für Diagnostische Radiologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany), Paris (Centre d Evaluation des Maladies Osseuses, Service de Rhumatologie, Assistance-Publique, Hôpital Cochin, Université René Descartes, Paris, France), and Sheffield (Division of Clinical Sciences, Northern General Hospital, Sheffield, UK). The study was coordinated by the Medizinische Physik in Kiel, Germany. All investigations were conducted in accordance with the Declaration of Helsinki and were approved by the appropriate institutional human research committee at each participating center. Participants of the OPUS study were recruited from random population samples between April 1999 and April In Germany, subjects were randomly selected from government-provided registers ( Einwohnermeldeamtslisten ). Subjects were initially contacted by mail. A similar procedure was followed in France, using registers of a complementary health insurance system. In Sheffield, we worked with several general practices and sent out letters of invitation to all women on their lists who met our inclusion criteria. In Aberdeen, women were selected randomly from a population health register of patients living within a 25-km radius of the city. In this first contact, subjects were asked to fill out a short questionnaire and to state whether they would be interested in participating in the examination at the local hospital. Subjects that expressed interest were contacted by phone, and the study visit was scheduled. No-shows were recontacted by phone to arrange a new appointment; subjects that again did not show up were excluded from the study. As recruitment progressed, the response rates stratified by 5-year age groups were monitored. To achieve a homogeneous distribution across the age range to be covered, the age distribution of remaining mail contacts was adjusted to enhance recruitment from age groups that were initially under-represented. We included women of two different age segments: years of age ( younger women ) or55 79 years of age ( older women ). Exclusion criteria were limited to disorders that precluded valid QUS measurements (i.e., bilateral fractures of the calcaneus, bilateral hip prostheses, disorder of the hand), general inability to undergo the specified exams, and cognitive limitations that preclude filling out self-administered questionnaires. Pregnant women were excluded because of potential risks associated with X-ray exposure. Examinations and questionnaires The visit involved a large number of examinations and questionnaires and took 5 h per participant. Ultrasound measurements: QUS was obtained on five different QUS devices. For measurements at the calcaneus, we used the following: Achilles (GE Lunar, Madison, WI, USA), UBIS 5000 (Diagnostic Medical Systems, Montpellier, France), DTU-one (OSI/Osteometer Meditech, Hawthorn, CA, USA), and QUS-2 (Quidel/Metra, San Diego, CA, USA). For measurements at the finger phalanges, we used the DBM Sonic BP (IGEA, Carpi, Italy). The following QUS variables were evaluated: speed of sound (SOS) on the Achilles, UBIS 5000, and DTU-one; broadband ultrasound attenuation (BUA) on all four calcaneus devices; stiffness index as a linear combination of BUA and SOS on the Achilles ; amplitude-dependent SOS (AD-SOS); and as secondary variables, bone transmission time (BTT) and ultrasound bone profile index (UBPI) on the DBM Sonic BP device. Each measurement was performed twice on each device, with interim repositioning of the subject. If the two measurements deviated by more than a predefined devicespecific threshold, a third measurement was obtained. The predefined device-specific threshold was set to three times the estimated precision error (1.5% for stiffness of the Achilles ; 1.7 and 4 m/s for SOS of DTU-one and UBIS 5000, respectively; 1, 0.5, and 2 db/mhz for BUA of the DTU-one, UBIS 5000, and QUS-2, respectively; and 10 m/s for AD-SOS of the DBMSonic BP. Please note that these

3 784 GLÜER ET AL. unstandardized precision errors should not be used to judge technique performance they cannot be compared without standardization according to the response rate of the variables, a topic that is beyond the scope of this paper). This resulted in the following thresholds: 4.5 for stiffness of the Achilles ; 5 and 12 m/s for SOS of DTU-one and UBIS 5000, respectively; 3, 1.5, and 6 db/mhz for BUA of the DTU-one, UBIS 5000, and QUS-2, respectively; and 30 m/s for AD-SOS of the DBMSonic BP. To obtain the final result for any variable of a given patient, we averaged two results if a third measurement had been taken, the two closest results were averaged. Bone densitometry: Bone densitometry was performed using DXA of the spine and the proximal femur in posteroanterior projection (Hologic QDR-4500; Hologic, Bedford, MA, USA in the Kiel, Paris, and Sheffield centers) or in antero-posterior projection (Lunar Expert devices; GE Lunar, Madison, WI, USA in the Aberdeen and Berlin centers). Radiography: Vertebral fracture status was determined for all women in the group of older women. Lateral spinal radiographs of the thoracic (breathing technique) and the lumbar spine were obtained using standardized procedures and were centrally evaluated in the center in Berlin. Other examinations: A number of other tests were performed that are not described in detail here. These included lateral imaging of vertebral deformities on the DXA devices, laboratory blood and urine assessments, functional tests on muscle status, balance, and pulse rate. Questionnaires: Each participants filled out a number of questionnaires. The OPUS risk factor questionnaire, a modified version of the EVOS risk factor questionnaire of the European Vertebral Osteoporosis Study, (19) was administered in interview fashion. It includes biographical questions, aspects of family history of osteoporosis, medical history (with a focus on fractures and falls), medications known to affect skeletal metabolism, nutrition and lifestyle aspects, etc. To assess health-related quality of life, a number of validated instruments and additional standardized questionnaires were used in self-administered fashion. Validated instruments included the Qualeffo (20) and the symptoms domain of the OQLQ (21) as osteoporosisspecific questionnaires and the EuroQol (22) and the SF12 (23) as generic quality of life questionnaires. Additionally, a Generalized Anxiety Questionnaire (24) was used in three of the centers (Berlin, Kiel, and Paris). Because little data from these questionnaires are used here, no further details are provided. Quality assurance and standardization Great care was taken to obtain results in standardized fashion and according to the manufacturers specifications. Standard operating procedures were defined in written form for QUS, DXA, and radiography. Detailed guidelines on how to administer the questionnaires were developed and discussed. To train the local study coordinators and key personal, a central start-up meeting was held in Kiel, Germany, in March 1998 (before study start). In addition, a number of technical quality control and standardization measures were implemented. Ultrasound measurements: The quality of the study procedures was assured by rigid quality control measures. These include the following components: Stability of the QUS equipment was monitored at the local centers by daily measurement of the manufacturer provided phantom plus weekly measurements of bone equivalent QUS standards (the Leeds phantoms (25) ) according to predefined routines. (26) Performance of the operators was assessed by the QUS coordinator of the study (RB). As a follow-up to the start-up training, he visited the centers twice during the course of the study. During these visits, crosscalibration measurements were performed by him using a set of CIRS cross-calibrations phantoms. (26) Measurements on RB were also obtained. Because QUS standardization measures have not been validated so far, the results reported here were not adjusted according to cross-calibration data. Assessment of the validity of such standardization measures is currently ongoing and will be reported independently. For this study, only descriptive observations regarding equipment performance will be given to show that the devices were in proper working condition. Bone densitometry: For DXA, quality assurance concepts and quality control procedures are well established. (27,28) DXA results were corrected for longitudinal changes (based on daily measurements of the European Spine Phantom (29) ) and differences among centers according to published methods. (28) Results of the same brand were adjusted according to the cross-calibration phantom data, whereas results of different brands were standardized by expressing DXA results as standardized BMD (sbmd). (30,31) For standardized BMD of the lumbar spine (sbmd spi ) the total BMD of vertebrae L 2 L 4 was evaluated. Subjects in whom less than two vertebrae could be evaluated were excluded from the analyses. For standardized BMD of the hip (sbmd hip ), the total BMD of the proximal femur was evaluated. Fracture assessment: Radiographs were taken according to the specifications of the standard operating procedures and were evaluated centrally by two radiologists (TB and GA). The procedure to assess fracture status combined morphometric measurements of vertebral height ratios and the qualitative interpretation of fracture status by a radiologist. This way osteoporotic fractures could be distinguished from deformities due to other causes, using established criteria. (32 34) For all vertebra considered as deformed in fashion typical for osteoporosis, the shape and the magnitude of deformation ( 20% height reduction) were noted. While the morphometric and the qualitative evaluations were performed at the same time, the grading was established independently. In only two cases, discrepant results were observed, and here the results of the quantitative morphometry were used, that is, the two cases were not considered as fractured despite of their status fractured based on qualitative radiological reading. Degenerative changes in the spine: In addition to the fracture assessment, all patients were also evaluated with regard to presence of degenerative changes in the thoracic or lumbar spine. Grading was performed according

4 ULTRASOUND, DENSITOMETRY, AND VERTEBRAL FRACTURES 785 TABLE 1. POPULATION CHARACTERISTICS OF PARTICIPANTS OF THE OPUS STUDY Variable Younger women (20 39 years old) Older women (55 79 years old) n Mean SD n Mean SD Height (cm) Weight (kg) BMI (kg/m 2 ) DXA spine sbmd (mg/cm 2 ) DXA spine sbmd, no deg (mg/cm 2 )* DXA hip sbmd (mg/cm 2 ) Achilles BUA (db/mhz) DTU-one BUA (db/mhz) UBIS 5000 BUA (db/mhz) QUS-2 BUA (db/mhz) Achilles SOS (m/s) DTU-one SOS (m/s) UBIS 5000 SOS (m/s) Achilles Stiffness Index (%) DBM BP AD-SoS (m/s) * Excluding participants with degenerative changes (i.e., lumbar Kellgren score 2). to the Kellgren score, (35) ranging from 1 (no degenerative changes) to 4 (severe degenerative changes). Separate scoring was done for the lumbar and the thoracic spine. In patients with Kellgren scores of 3 or 4 for the lumbar spine, it may not have been possible to obtain accurate spinal bone density results using DXA because of the overlying ossifications. Questionnaires: For the questionnaires, the accuracy of the translation had to be assured. The questionnaires used in OPUS either consisted of instruments previously validated for the English, German, and French languages, (19,36,37) or they were translated and back-translated by the OPUS team. Statistical methods All statistical evaluations, except otherwise noted, were carried out using JMP software (SAS Institute, Cary, NC, USA). Goodness of fit tests for normal distributions were based on 2 tests. Tests for differences among multiple groups were based on the Tukey Kramer HSD test. The association of DXA or QUS variables with vertebral fracture status were analyzed using logistic regression analysis. For most variables, the distribution was close to normal, and for consistency, we have treated all statistics parametrically here. Results were expressed as standardized odds ratios (sors), that is, the increase in the odds of fracture per 1 population SD decrease in the respective DXA or QUS variable. For age-adjusted ORs, the SE of the estimate (SEE) of linear age-related decreases was used for standardization. Differences in the discriminatory power of techniques were analyzed by receiver operating characteristics (ROC) analysis using the ROCKIT software (38) and were based on a two-sided test comparing the areas under the curves (AUC). Using multivariate logistic regression analysis, we also investigated whether a combination of several QUS or DXA variables would improve the ability to identify subjects at high risk of prevalent vertebral fractures. A p value of less than 0.05 was considered significant, and a trend was defined as 0.05 p RESULTS Baseline characteristics and confounders For this report, we present results from both the group of younger and older women. For the group of younger women recruited, we report data from those 463 who were years of age at the time of the study visit, had a valid DXA measurement of the femur, and had filled out the questionnaires. For the group of older women, we report results from those 2374 who were years of age at the time of the study visit, had a valid DXA measurement of the femur, had radiographs of sufficient quality to allow assessment of vertebral fracture status, and had filled out the questionnaires. Ninety-nine percent of the women were of white ethnicity. A total of 379 (16.0%) of the older women had one or more vertebral osteoporotic fractures, and 147 (6.2%) of them had multiple osteoporotic fractures. Among the 379 women with osteoporotic vertebral fractures (i.e., a vertebral height reduction of more than 20%), the height reduction of the most severely affected vertebra exceeded 25% in 270 participants (11.4%), 30% in 214 participants (9.0%), 35% in 174 participants (7.3%), and 40% in 135 participants (5.7%). Lumbar Kellgren scores showed the following distribution: 170 women (7.1%) grade 1, 946 (39.8%) grade 2, 894 (37.7%) grade 3, and 364 (15.3%) grade 4. Table 1 lists the baseline characteristics of the two groups. Numbers of examinations differ among variables because two devices were not installed in Paris (Achilles and QUS-2) and because of temporary equipment breakdown. Both in the younger and the older group we noted significant differences among centers with regard to height (greatest in Kiel and Berlin, the younger women of the German sites were cm taller than women at the three other sites), weight (for young women, they were highest in Sheffield and lowest in Paris, with a significant difference of 7.3 kg between these sites; in older women, they were lowest in Paris, significantly lower by kg

5 786 GLÜER ET AL. TABLE 2. UNADJUSTED AND AGE-ADJUSTED PREDICTION OF VERTEBRAL FRACTURE STATUS Variable n All women age Subset of 1265 women BMD or QUS Age BMD or QUS BMD or QUS sor (95% CI) OR/10yrs (95% CI) SEE Ageadjusted sor (95% CI) SEE Ageadjusted sor (95% CI) AUC DXA spine sbmd ( ) ( ) ( ) ( ) DXA hip sbmd ( ) ( ) ( ) ( ) Achilles BUA ( ) ( ) ( ) ( ) DTU-one BUA ( ) ( ) ( ) ( ) UBIS 5000 BUA ( ) ( ) ( ) ( ) QUS-2 BUA ( ) ( ) ( ) ( ) Achilles SOS ( ) ( ) ( ) ( ) DTU-one SOS ( ) ( ) ( ) ( ) UBIS 5000 SOS ( ) ( ) ( ) ( ) Achilles Stiffness Index ( ) ( ) ( ) ( ) DBM BP AD-SoS ( ) ( ) ( ) ( ) Unadjusted standardized odds ratio (sor, column 3) given per decrease by 1 SD of the results (specified in Table 1) for women years of age. For age-adjusted models, OR per 10-year increase in age (OR/10yrs, column 4) given along with age-adjusted sor (column 6) given per decrease by the SE of the estimate (SEE, column 5) of linear age-related models of DXA or QUS for women years of age. All sor for QUS or BMD variables are specified with 95% CIs. Data shown for all women (columns 2 6), and for comparison based on area under the curve (AUC) of ROC analysis, also for the subset with complete set of diagnostic measurements (columns 7 9). than women at any other site), and body mass index (BMI; in younger and older women, they were highest in Sheffield, and significantly higher by kg/m 2 in younger women and kg/m 2 in older women than women at the three sites outside the UK; in older women, they were lowest in Paris, and significantly lower by kg/m 2 than women at any other site). Fracture discrimination When relating DXA and QUS results with prevalence of vertebral fractures, all methods showed significant associations. Table 2 (column 3) shows unadjusted sors (per 1 SD decrease, using the SD of the group of older women). For the relationship of DXA and QUS with fracture prevalence, age was a significant confounder for all variables tested. Results for age-adjusted logistic regression are also summarized in Table 2, separating data for the maximum size set of subjects for any given DXA or QUS variable (columns 2 and 4 6) and data obtained on the subset of the 1265 women with complete information on all DXA and QUS variables assessed (columns 7 9). The ranking of techniques was virtually identical for age-adjusted and unadjusted models (comparing columns 3 and 6). However, age-adjusted models showed better discrimination of fractured and unfractured individuals than unadjusted models, reflecting the independent contribution of age and the respective BMD or QUS variable. After adjusting for age, the following results were observed for additional confounding variables. Neither height nor weight nor BMI by themselves showed any ageadjusted association with fracture status. Confounders in the association of DXA or QUS variables with fracture status height again did not contribute independently. Weight, however, was a significant confounder for the association of age-adjusted DXA of the spine (p 0.02) and age-adjusted DXA of the total hip (p 0.003) with fracture prevalence. After adjusting for age and the respective BMD variable, fracture risk increased, with an OR of 1.2 per SD (12.4 kg) increase in weight. BMI also was a significant confounder for fracture status assessed by age-adjusted DXA of the spine and DXA of the total hip (p 0.03 and p 0.001, respectively): fracture risk increased with ORs of 1.15 and 1.25 per SD (4.5 kg/m 2 ) increase in BMI, respectively. Neither height, weight, nor BMI showed a significant effect for the association of the QUS variables studied with vertebral fracture status. Differences among centers also did not affect any of the associations of DXA or QUS with vertebral fracture status. A separate analysis of women with

6 ULTRASOUND, DENSITOMETRY, AND VERTEBRAL FRACTURES 787 FIG. 1. Sensitivity of QUS variables compared with bone densitometry for identifying subjects with prevalent vertebral fractures. Sample results shown for two BMD and three QUS variables: BMD of the lumbar spine, BMD of the total proximal femur, SOS of the Achilles, BUA of the Quidel/Metra QUS-2, and AD-SOS of the IGEA DBM- Sonic BP. Results are based on a subset of 1265 women for whom all variables were obtained completely and were calculated from ageadjusted logistic regression analysis of the respective DXA or QUS variable. different levels of degenerative change in the lumbar spine revealed slightly higher ORs for DXA of the spine if those 1258 women with lumbar Kellgren scores greater than 2 were excluded. The standardized age-adjusted OR increased to 1.60 but only if the population SD of the entire data set was still used. If this was calculated only for the subset with lumbar Kellgren scores less than 2, the standardized ageadjusted ORs returned to the value of 1.55 listed in Table 2. Consequently, all further analyses were performed without excluding subjects with higher lumbar Kellgren scores. The age-adjusted associations of the various variables with vertebral fracture prevalence were also analyzed by ROC analysis in the 1265 women with complete data sets (areas under the ROC curves listed in Table 2). Only small differences were observed (range AUC, ). Compared with DXA of the hip or spine, no significant differences were observed for any of the QUS variables. SOS of the Achilles had a significantly higher AUC compared with BUA of the UBIS 5000, and SOS of the UBIS 5000 had a significantly higher AUC compared with BUA of the Achilles. No other significant differences were observed among QUS variables. However, when comparing SOS and BUA obtained on the same device, SOS always showed somewhat better results, with AUCs at least as good as those observed for DXA (see also data on combinations of variables reported below). The secondary QUS variables available on the DBM BP (BTT and UBPI) did not offer any improvement over AD-SOS. The stiffness index provided on the Achilles showed performance levels between those observed for BUA and SOS on this device. To improve the statistical power for detecting differences in performance among QUS variables, AUCs were also calculated for the data set of maximal size for each pair of variables. Again, equivalent performance compared with DXA of the spine and hip was observed for SOS of the Achilles, SOS of the UBIS 5000, and BUA of the QUS-2 (with differences in AUC ranging between 0.01 and 0.018). For the other variables, trends or even significant differences in AUC compared with DXA of the spine and the hip were found: SOS of the DTU-one (p 0.05 and p 0.04), BUA of the Achilles (p 0.02 and p 0.06), BUA of the DTU-one (p and p 0.002), BUA of the UBIS (p 0.11 and p 0.12), and AD-SOS of the DBM BP (p and p 0.001) AUC differences between DXA and QUS variables ranged between and AUC differences among QUS variables were generally smaller and not significant. SOS again showed somewhat better performance compared with BUA obtained on the same device, but significantly better performance was observed only for SOS of the Achilles compared with BUA of the DTU-one and for SOS of the UBIS 5000 compared with AD-SOS of the DBM BP. We also analyzed the discriminatory power of the various techniques for vertebral deformities considered to be solely of degenerative origin. Eighty cases showed only degenerative deformities and no osteoporotic fractures, and 95% of them had Kellgren scores greater than 2 in either the thoracic or in the lumbar region. When we compared those 80 cases with cases without deformities, no significant ageadjusted difference was observed for any of the DXA or QUS variables. Fracture detection efficiency Bone densitometry and QUS methods could potentially be used to identify women at highest risk of having a vertebral fracture most likely unknown to them. For these women, spinal radiography might be justified. To study whether the observed differences in the gradients of risk would result in substantial performance differences among devices, we calculated the sensitivity of the techniques to identify women with prevalent osteoporotic vertebral fractures. Sensitivity was plotted as a function of the X-ray referral rate ranging from 0% to 100%. An X-ray referral rate of 20%, for example, would mean that those 20% of the subjects with the highest estimated vertebral fracture risk (calculated from the age-adjusted logistic regression analysis of the respective DXA or QUS variable under study) would be referred for further radiographic fracture examination. Based on the diagnostic result of the radiographic assessment, the sensitivity and specificity of BMD or QUS variables for predicting a patient s true fracture status can be calculated. Results for two BMD variables and three selected QUS variables are displayed in Fig. 1. The presentation mode is similar to ROC curves, but for ease of interpretation here, the X-ray referral rate was directly used as an independent variable instead of 1 specificity ; the maximal differences between X-ray referral rate and 1 specificity are 4%. As for ROC curves, the performance of a purely random selection of participants to be referred to an X-ray exam would be represented by the diagonal. The vertical

7 788 GLÜER ET AL. distance between any of the curves and the diagonal represents the increase in the rate of vertebral fractures detected. As seen in Fig. 1, the increase in sensitivity typically ranges around 20%. Another way to represent the performance is depicted in Fig. 2, where it is expressed as the number of cases to be X-rayed (NNX) to detect one vertebral fracture, as calculated from age-adjusted logistic regression models. In the general population of the older group, the number of X-rays to be taken to detect one vertebral fracture (NNX) could be cut in half from 6.3 to 3, if only the 10% women at highest risk were to be targeted based on calcaneal QUS or central DXA, whereas for AD-SOS of the finger phalanges, a corresponding reduction to 4 could be achieved. A reduction to 4 5 would be the limit for selection based on age alone. When selecting the 10% women at highest risk in ageadjusted models, DXA and QUS showed agreement in 90% of the cases. Comparing the various QUS devices to DXA of the spine, the score ranged for BUA, for SOS, and for DBM variables, and it was 0.49 for the stiffness index of the Achilles. Comparing them to DXA of the total hip, the score ranged for BUA, for SOS, and for DBM variables, and it was 0.52 for the stiffness index of the Achilles. The magnitude of the age-adjusted standardized ORs was also studied for vertebral deformities of different severity. Figure 3 shows ORs for the variables tested as a function of the maximum reduction in vertebral height for a given participant. The analysis was performed on the subset of 1265 women with complete DXA and QUS data. As can be seen, with increasing severity of the fracture, the ORs increase substantially for most variables, but not for AD- SOS at the finger phalanges. While no significant differences could be observed, the following ranking of the techniques was observed for the most severe fractures (40% height reduction): the strongest risk ratios were calculated for SOS of the DMS UBIS 5000 with srr 2.3( ), SOS of the GE Lunar Achilles with srr 2.2( ), and SOS of the Osteometer DTU-one with srr 2.0( ), followed by DXA of the spine with srr 1.9( ) and the total femur with srr 1.7( ). Somewhat lower ORs were achieved for BUA of the calcaneus, and the standardized age-adjusted ORs for the QUS variables of the finger phalanges were no different from the levels observed for less severe vertebral fractures (Fig. 3). Because of the small number of fractures per group, the above differences between variables did not reach significance in ROC analyses. Combinations of variables We also investigated whether a combination of several QUS or DXA variables would improve the ability to identify subjects at high risk of prevalent vertebral fractures. When combining two QUS variables in an age-adjusted model, no significant improvement over single age-adjusted QUS variables could be achieved. In the data set of the 1265 older women for whom complete information on all DXA and QUS variables was available, this was tested for SOS FIG. 2. The number of women to be X-rayed (NNX) to detect one additional vertebral fracture displayed as a function of the X-ray referral rate. In the highest risk group of 5 20% of the general population of year olds, the number can be reduced from 6.3 to if preselection was based on age-adjusted BMD or calcaneal QUS results and to 4 for QUS finger measurements. Sample results shown for two BMD and three QUS variables: BMD of the lumbar spine, BMD of the total proximal femur, SOS of the Achilles, BUA of the Quidel/Metra QUS-2, and AD-SOS of the IGEA DBMSonic BP. For comparison, results for selection based on age alone are also shown. Results are based on a subset of 1265 women for whom all variables were obtained completely. and BUA of the same device, several SOS (or BUA) variables of different calcaneal QUS devices, and SOS of the calcaneus in combination with AD-SoS of the finger phalanges. The stronger performance of SOS was confirmed in multivariate logistic regression models: if both BUA and SOS of a given device were included in an age-adjusted model of vertebral fracture status, only SOS, and not BUA, was highly significant. Although independent contributions were observed for BUA of any of the QUS devices in combination with AD-SOS, the combined predictive power was still smaller compared with age-adjusted SOS of any device. BMD of the spine and the total femur did not show independent age-adjusted associations with fracture status in the data set of the 1265 women (only in the larger data set of 2340 women). All QUS variables except for BUA of the Achilles and BUA of the DTU-one showed significant associations with fracture status independent of either BMD of the spine or the hip (large data set). For SOS of the Achilles and SOS of the UBIS 5000, the strongest independent contributions were observed with p for SOS in models with BMD of the spine and p for SOS in models with BMD of the hip. The p values for the BMD variables in these combined models were always smaller than those for the QUS variables at p The strongest combination was obtained for BMD of the spine and SOS of the Achilles with an AUC of 0.68 (and 0.69 once adjusted for weight), up from AUC 0.67 for either

8 ULTRASOUND, DENSITOMETRY, AND VERTEBRAL FRACTURES 789 FIG. 3. Discriminatory power for DXA and QUS variables for osteoporotic vertebral fractures of increasing severity (maximum height reduction ranging from 20% to 40% in any of the vertebrae). of the two variables alone (difference in AUC not significant). The resulting improvement (e.g., expressed as a reduction of NNX for BMD of the spine and SOS of the Achilles compared with NNX based on age-adjusted BMD of the spine alone) was minimal (an average reduction of 3%, e.g., from NNX 3toNNX 2.91). DISCUSSION A broad range of diagnostic techniques is available for the assessment of osteoporosis. These include radiological imaging techniques both X-ray and ultrasound-based, laboratory tests for the evaluation of biochemical or genetic markers, functional tests, and instruments for the assessment of risk factors. Many of them have been developed or updated in the past few years, and therefore, only limited information about their performance can be obtained from the large epidemiological osteoporosis studies started years ago such as SOF, (39) EPIDOS, (40) or the Rotterdam Study. (41) Even less data are available for a comparative assessment or for evaluation of their combined use. To develop a multidisciplinary assessment strategy for osteoporosis based on a comprehensive range of state-ofthe-art diagnostic measurements, we initiated the OPUS study. A population-based sample of Western European younger and older women underwent a comprehensive range of diagnostic tests at the five participating centers. In this first report from the OPUS study, we focus on the cross-sectional performance of five different QUS devices, specifically comparing their ability to identify subjects at risk for prevalent vertebral fractures other variables are currently being evaluated, and the first prospective data are being collected. The need to present comprehensive wellcontrolled QUS data are pressing, because to date, reports have either focused on few isolated or discontinued QUS devices (6,7,12) or have not compared QUS performance directly head to head with gold standard methods such as DXA. (8,14) Smaller studies have provided partly discrepant and therefore confusing results. As a consequence, substantial criticism regarding QUS has been voiced. Moreover, because of the lack of consensus about appropriate use and interpretation of QUS methods and results, misuse is increasingly being reported not so much in the scientific literature but at many osteoporosis meetings that cover diagnostic strategies of how to fight osteoporosis. The OPUS study is powered to provide evidence-based data for a variety of different QUS approaches, in direct comparison with competing techniques, to address the questions about the strengths and limitations of ultrasound approaches. As the first main performance test, we report the association of nine QUS variables obtained on five different QUS devices with the prevalence of radiologically defined vertebral fractures. All devices, both those measuring at the calcaneus and the one measuring at the finger phalanges, showed significant discriminatory power even after adjusting for age. The highest ORs were achieved for SOS measurements at the calcaneus, and the fracture association reached levels equivalent to the values observed for central DXA measurements on the same subjects. In other words, the vertebral fracture discrimination observed for a direct measurement at the spine was no stronger than for the best peripheral ultrasound-based measurement at the calcaneus. Unlike DXA, fracture risk associations based on QUS variables were not significantly affected by height, weight, or BMI, facilitating the interpretation of results. We observed some significant differences in performance among DXA and QUS techniques, but the small differences in AUCs from ROC analysis indicate that few of them may be clinically important. For each of the three devices that allowed measuring of BUA and SOS, SOS proved to be superior in performance with regard to the association with vertebral fractures, most notably in multivariate models including BUA and SOS. Consequently, for the purpose of fracture risk assessment, a clinical user may be well advised to concentrate on the SOS result if available. The additional information on risk provided by BUA is not likely to be clinically relevant. The situation is different for the Quidel/ Metra QUS-2, which only provides BUA data and which showed fracture discrimination equivalent to central DXA. AD-SOS measurements at the finger phalanges also showed significant age-adjusted associations with fracture status, but the AUCs calculated by ROC analysis, while statistically insignificantly different from calcaneal ultrasound results (except for SOS of the UBIS 5000 evaluated on the large sample), were significantly lower compared with the

9 790 GLÜER ET AL. level observed for central DXA methods (p 0.05); the secondary QUS variables BTT and UBPI available on the DBM Sonic BP did not offer improvements compared with AD-SOS. The sample size differed quite substantially among QUS variables, ranging from 1552 to Consequently, the power to detect significant differences also varied in the analyses that were based on pairwise data sets of maximum size, making a comparison of levels of significance difficult. However the differences in AUCs paralleled the p values observed and thus the ranking of techniques should be valid. Age was an independent predictor of fracture status for all variables tested. A combined model that included age and the respective BMD or QUS variable showed stronger discrimination compared with the univariate model of unadjusted BMD or QUS variables. The data provided in Table 2 can be used to calculate the combined effect of age and the QUS or BMD variable according to the formula (age difference)/10years OR(age, method) OR(age) (method difference)/see OR(method) where OR(age) is specified in column 4, OR(method) in column 6, and SEE in column 5 of Table 2. For example, two women with an age difference of 15 years and an Achilles SOS difference of 39.5m/s (1.5 SEE or 1.4 SD of older women) would have odds of having a vertebral fracture that differed by a factor of OR If only judged by their unadjusted ORs, the factor would only be OR The strong performance compared with central DXA observed for the state-of-the-art calcaneal QUS devices compares favorably with the data reported for earlier devices. In their meta-analysis, Marshall et al. (42) reported standardized risk ratios (srrs) for predicting vertebral fractures for calcaneal ultrasound of srr 1.8( ), compared with srr 2.4( ) for X-ray based calcaneal measurements and srr 2.3( ) for spinal DXA measurements. Their ultrasound data, however, were only based on two retrospective studies (43,44) that both used an ultrasound device that has long been discontinued (Walker Sonix UBA 575). The Hawaii group afterward published a prospective study reporting an srr 1.5(1.1,2.2) for calcaneal QUS on that device, again lower than BMD, in this case measured at the hand. The only other prospective study relating ultrasound and DXA with vertebral fracture incidence showed similar results, although the sample size was small and the CIs were correspondingly large. (45) In the time since the meta-analysis of Marshall et al., a number of cross-sectional studies investigating the power of QUS for discriminating vertebral fracture in direct comparison with central DXA have been reported with mixed results. It is interesting to note that the performance of QUS, specifically SOS of the calcaneus, was equivalent to spinal DXA in both of the recent population-based studies: the Basel Osteoporosis Study (46) and the OPUS study reported here. When comparing discriminatory power for vertebral fractures for DXA versus QUS, a steep increase in the ORs with increasing degree of deformation was observed for calcaneal QUS variables, somewhat stronger and more consistent than the increases observed for DXA of the spine or the total femur (see Fig. 3). The difference in areas under the ROC curves, however, did not reach statistical significance. This may be explained by the small sample size per fracture group and the limited power of ROC analysis in general. Our observation of strong performance of QUS for more severe fractures confirms a similar report stating that QUS associations with multiple vertebral fractures were somewhat stronger than spinal DXA measurements obtained in the same study group. (46) The standardized age-adjusted ORs observed in our study for DXA of the spine and the hip were somewhat lower than in most other studies (on average srr 1.8 and srr 2.3 for DXA hip and spine, respectively, in Marshall s metaanalysis (42) ). Differences in the SEE used for standardization and in the definition of vertebral fractures may have contributed. As seen in Fig. 3, the age-adjusted sors generally increased with increasing severity of the fractures. We investigated whether the discriminatory power of spinal DXA (and perhaps other techniques) was potentially impeded by the presence of degenerative changes. We observed virtually identical age-adjusted sors if we excluded those 1258 cases that had Kellgren scores 2 in the lumbar spine region. The discriminatory power of DXA of the total femur was not affected either. Thus, the good performance of QUS compared with DXA in assessing vertebral fracture status was not caused by DXA problems caused by degenerative changes. Interestingly, we noted that age-adjusted sors in subjects with Kellgren score 3 were 3 16% higher for the QUS results obtained at the calcaneus but not at the finger phalanges. With an increase of 13 16%, this difference was most pronounced for the Achilles and the QUS-2. Because the 1258 cases with higher Kellgren scores were included in all other analyses presented here, the reported performance of QUS can be considered to be a conservative estimate. The limited impact of high Kellgren scores on discriminatory power for spinal DXA should not be used as an argument to disregard degenerative changes in the process of diagnostic assessment of individual patients. Here the bias introduced by degenerative calcifications needs to be considered, and affected vertebrae may need to be excluded from the analysis. Even more important is the related topic of degenerative deformities. Our observation that for any of the DXA or QUS variables no significant difference could be observed between cases with degenerative deformities only on the one hand and subjects without deformities on the other hand supports our assumption that those deformities had not been caused by low bone mass. These findings also emphasize the need to perform a careful radiological differential diagnosis to distinguish osteoporotic from nonosteoporotic vertebral deformities. Well-defined and validated criteria, such as those used in this study, may be helpful to employ in clinical practice. The results also provide further evidence that the low QUS readings are related to low bone mass and not to some other property that would be similarly reduced in subjects with degenerative disease.

10 ULTRASOUND, DENSITOMETRY, AND VERTEBRAL FRACTURES 791 Except for age, which showed the expected consistent association with fracture risk in univariate (OR of 1.7/10- year age increment) and multivariate models, other potential confounders like body height, weight, or BMI had no effect on the association of QUS with vertebral fracture risk. The association of DXA variables with fracture risk, on the other hand, was significantly confounded by weight, or alternatively, BMI. The observed positive relationship between DXA-adjusted weight or BMI and vertebral fracture risk was unexpected. In the EPOS study low weight and low BMI (not adjusted for BMD) showed nonsignificant trends with increased osteoporotic vertebral fracture risk. (47) A different study reported that such associations were eliminated once weight was adjusted for BMD. (48) Whether our observation indicates that the relationship of weight and BMI with vertebral fractures is different from that observed for hip fractures (where low weight and BMI are commonly reported as independent risk factors) remains to be tested in a prospective study. Potentially, the relationship may also have been affected by the fat error of DXA. (49,50) Combinations of DXA and QUS showed only limited benefits with regard to fracture discrimination. This was observed for combinations of several QUS variables, combinations of several DXA variables, and combinations of QUS and DXA variables, whether the combination was based on linear combinations of the variables or whether it was based on the minimum Z-score. However, the fact that statistically significantly independent contributions were observed for some QUS and DXA variables, with the most powerful combination being based on spinal DXA and calcaneal SOS, indicates that combined assessments of these two variables may provide important information for some individuals. It is only for a population-based sample like the one investigated here that a general combination of (any) two approaches tested across all patients does not provide substantial benefits for fracture discrimination. For similar reasons, ROC analysis in general has limited power to detect smaller differences among diagnostic techniques, whereas logistic models more readily allow to detect significant independent associations. DXA and QUS methods are not suited for diagnosing fractures. Therefore, the modest sensitivity to identify women with prevalent fractures in a population-based sample is not surprising and is in agreement with previous reports for example, the cut-off values of the WHO criteria (51) have been set to achieve high specificity at the expense of low sensitivity. (52) However,, it is relevant to develop a strategy to identify subjects at highest risk for having a vertebral fracture, unknown to themselves. Even under health-economic constraints, subjects with prevalent osteoporotic vertebral fracture are in undisputed need for effective treatment because they not only suffer from pain and limitations in daily living, (53) but they are at high risk for additional fractures within a short time period. (54) However, only about one-third of all women with prevalent vertebral deformities know of their health problem, (55,56) but even those who are not aware of their fracture already suffer from back pain (57) not attributed by them to osteoporotic fracture. Therefore, low-cost strategies to identify women with prevalent vertebral fracture can be valuable. Our findings indicate that QUS and DXA methods are equally well suited for this task, but DXA has the disadvantages of higher cost and ionizing radiation. High-risk patients could also be selected based on age, but QUS or BMD are required to obtain addition benefits in the high-risk groups. The NNX data displayed in Fig. 2 give an indication how much can be gained in a population-based sample that could be relevant for cost-effectiveness assessments. However, for the assessment of the individual patient strategies based on age alone have obvious limitations because risk profiles of younger individuals also need to be assessable. The performance of SOS is particularly strong for women with more severe fractures for which the risk for future fractures is higher than for mild fractures. For population-based QUS (or DXA) screening, the number of women to be referred to radiography of the spine can be reduced by one-half in the higher-risk group. However, the most likely strategy would not be a population-based QUS (or DXA) screening but evaluation of a targeted high-risk group by means of one of those two methods. For this purpose the identification of risk factors for low QUS needs to be pursued. If one were able to identify the group corresponding to those 10 15% of our older groups at highest risk, about one in three women would have a prevalent osteoporotic vertebral fracture. Interestingly, the agreement between QUS- and DXA-based identification of the high-risk group was quite good, with scores ranging up to 0.56 for DXA of the hip and 0.52 for DXA of the spine. Alternatively, as treatment with a bisphosphonate significantly reduces further vertebral fracture rates by 50%, regardless of whether or not the women have BMD-defined osteoporosis, (58) strategies might be developed where treatment of women with very low QUS with a potent bisphosphonate could reduce vertebral fracture rates without the need for central DXA or even radiographs. The effectiveness of strategies such as those described here would have to be tested in a prospective randomized study. In conclusion, we have demonstrated in a populationbased sample that all of the five QUS approaches tested allow identification of women at high risk for prevalent osteoporotic vertebral fractures. Performance differences among QUS variables were modest, but SOS of the calcaneus showed the best performance. Using the strongest variable available for a given device, three of the four calcaneal QUS devices discriminated women with and without vertebral fractures as well as central DXA measurements. Targeted QUS-based case finding strategies would allow for half the number of radiographs in high-risk populations. Compared with SOS of the calcaneus or central DXA, BUA results obtained on the same device and all variables at the finger phalanges showed somewhat less strong performance. The good performance of BUA on the device that does not measure SOS demonstrated that BUAbased results can also show fracture discrimination equivalent to central DXA. SOS of the calcaneus and central DXA measurements showed statistically independent association with fracture prevalence, but the increase over single ageadjusted predictors was small for our population-based sample. The statistically independent association indicates that SOS and DXA results both have relevance for fracture risk of individuals. Targeting subgroups at highest risk enhances

Diagnosis of Vertebral Fractures by Vertebral Fracture Assessment

Diagnosis of Vertebral Fractures by Vertebral Fracture Assessment Journal of Clinical Densitometry, vol. 9, no. 1, 66 71, 2006 Ó Copyright 2006 by The International Society for Clinical Densitometry 1094-6950/06/9:66 71/$32.00 DOI: 10.1016/j.jocd.2005.11.002 Original

More information

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p. Dedication Preface Acknowledgments Continuing Education An Introduction to Conventions in Densitometry p. 1 Densitometry as a Quantitative Measurement Technique p. 2 Accuracy and Precision p. 2 The Skeleton

More information

Accuracy of DEXA scanning & other methods for determining BMD.

Accuracy of DEXA scanning & other methods for determining BMD. BMD- Measurement Site Accuracy of DEXA scanning & other methods for determining BMD. Ann Larkin In general, densitometry techniques can be performed in either the axial or the appendicular skeleton, depending

More information

New Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment

New Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment Case 1 New Dual-energy X-ray Absorptiometry Machines (idxa) and Vertebral Fracture Assessment (VFA) History and Examination Your wealthy friend who is a banker brings his 62-year-old mother to your office

More information

Omnisense: At Least As Good As DXA

Omnisense: At Least As Good As DXA Omnisense: At Least As Good As DXA The following document summarizes a series of clinical studies that have been conducted to compare between different qualities of the Sunlight support the claim that

More information

Documentation, Codebook, and Frequencies

Documentation, Codebook, and Frequencies Documentation, Codebook, and Frequencies Dual-Energy X-ray Absorptiometry Femur Bone Measurements Examination Survey Years: 2005 to 2006 SAS Transport File: DXXFEM_D.XPT January 2009 NHANES 2005 2006 Data

More information

2013 ISCD Official Positions Adult

2013 ISCD Official Positions Adult 2013 ISCD Official Positions Adult These are the Official Positions of the ISCD as updated in 2013. The Official Positions that are new or revised since 2007 are in bold type. Indications for Bone Mineral

More information

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:

More information

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA ORIGINAL ARTICLE Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA Leila Amiri 1, Azita Kheiltash 2, Shafieh Movassaghi 1, Maryam Moghaddassi 1, and Leila Seddigh 2 1 Rheumatology

More information

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis

More information

Official Positions on FRAX

Official Positions on FRAX 196 96 DEPLIANT 3,5x8,5.indd 1 2010 Official Positions on FRAX 21.03.11 11:45 Interpretation and Use of FRAX in Clinical Practice from the International Society for Clinical Densitometry and International

More information

Assessment of the risk of osteoporotic fractures in Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles

Assessment of the risk of osteoporotic fractures in Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles Assessment of the risk of osteoporotic fractures in 2008 Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles Estimated lifetime fracture risk in 50-year-old white women and men Melton et al.;

More information

9 Quality Assurance in Bone Densitometry section

9 Quality Assurance in Bone Densitometry section 9 Quality Assurance in Bone Densitometry section Introduction Bone densitometry is frequently used to determine an individual's fracture risk at a particular point in time but may also be used to assess

More information

MEDILINK PEGASUS Smart. The New Portable ultrasound Bone densitometer

MEDILINK PEGASUS Smart. The New Portable ultrasound Bone densitometer MEDILINK PEGASUS Smart The New Portable ultrasound Bone densitometer MEDILINK Specialised in Bone densitometry A subsidiary dedicated to Radiology Field Represented in more than 100 countries worldwide

More information

Dr Andrew Scourfield Chelsea and Westminster Hospital, London

Dr Andrew Scourfield Chelsea and Westminster Hospital, London 17 TH ANNUAL CONFERENCE OF THE BRITISH HIV ASSOCIATION (BHIVA) Dr Andrew Scourfield Chelsea and Westminster Hospital, London 6-8 April 2011, Bournemouth International Centre The use of calcaneal stiffness

More information

PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302)

PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302) PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302) Date of Interview/Examination (MM/DD/YYYY): A downloadable PDF

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/28958 holds various files of this Leiden University dissertation Author: Keurentjes, Johan Christiaan Title: Predictors of clinical outcome in total hip

More information

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure?

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure? Scan for mobile link. Bone Densitometry What is a Bone Density Scan (DXA)? Bone density scanning, also called dual-energy x-ray absorptiometry (DXA) or bone densitometry, is an enhanced form of x-ray technology

More information

Osteodensitometry in primary and secondary osteoporosis

Osteodensitometry in primary and secondary osteoporosis Osteodensitometry in primary and secondary osteoporosis Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Research question The main goal of the present research was the assessment

More information

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi Clinical Utility of Bone Densitometry Diagnosis (DXA)

More information

Dual-energy Vertebral Assessment

Dual-energy Vertebral Assessment Dual-energy Vertebral Assessment gehealthcare.com Dual-energy Vertebral Assessment More than 40% of women with normal or osteopenic BMD had a moderate or severe vertebral deformation seen with DVA. Patrick

More information

Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density in Identifying the Risk of Osteoporosis in Elderly Taiwanese Women

Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density in Identifying the Risk of Osteoporosis in Elderly Taiwanese Women TZU CHI MED J September 2008 Vol 20 No 3 available at http://ajws.elsevier.com/tcmj Tzu Chi Medical Journal Original Article Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density

More information

Lecture Outline. Biost 590: Statistical Consulting. Stages of Scientific Studies. Scientific Method

Lecture Outline. Biost 590: Statistical Consulting. Stages of Scientific Studies. Scientific Method Biost 590: Statistical Consulting Statistical Classification of Scientific Studies; Approach to Consulting Lecture Outline Statistical Classification of Scientific Studies Statistical Tasks Approach to

More information

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster DOI 10.1007/s00296-012-2460-y ORIGINAL ARTICLE Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security

More information

Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status

Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status Journal of Clinical Densitometry, vol. 10, no. 3, 239e243, 2007 Ó Copyright 2007 by The International Society for Clinical Densitometry 1094-6950/07/10:239e243/$32.00 DOI: 10.1016/j.jocd.2007.03.002 Original

More information

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men Osteoporos Int (1999) 10:265 270 ß 1999 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Bone Mineral Density and Vertebral Fractures

More information

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status.

Objectives. Discuss bone health and the consequences of osteoporosis on patients medical and disability status. Objectives Discuss bone health and the consequences of osteoporosis on patients medical and disability status. Discuss the pathophysiology of osteoporosis and major risk factors. Assess the major diagnostic

More information

Norland Densitometry A Tradition of Excellence

Norland Densitometry A Tradition of Excellence Norland Densitometry A Tradition of Excellence Norland DXA Bone Density Measurement Osteoporosis is a disease marked by reduced bone strength leading to an increased risk of fractures. About 54 million

More information

Purpose. Methods and Materials

Purpose. Methods and Materials Prevalence of pitfalls in previous dual energy X-ray absorptiometry (DXA) scans according to technical manuals and International Society for Clinical Densitometry. Poster No.: P-0046 Congress: ESSR 2014

More information

Quality Control of DXA System and Precision Test of Radio-technologists

Quality Control of DXA System and Precision Test of Radio-technologists J Bone Metab 2014;21:2-7 http://dx.doi.org/10.11005/jbm.2014.21.1.2 pissn 2287-6375 eissn 2287-7029 Review Article Quality Control of DXA System and Precision Test of Radio-technologists Ho-Sung Kim 1,

More information

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women International Endocrinology Volume 3, Article ID 895474, 5 pages http://dx.doi.org/.55/3/895474 Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women Na Li, Xin-min

More information

Opportunistic screening for osteoporosis on routine computed tomography? An external validation study

Opportunistic screening for osteoporosis on routine computed tomography? An external validation study Eur Radiol (2015) 25:2074 2079 DOI 10.1007/s00330-014-3584-0 COMPUTED TOMOGRAPHY Opportunistic screening for osteoporosis on routine computed tomography? An external validation study Constantinus F. Buckens

More information

Standard Operating Procedure TCRC Dual-Energy X-ray Absorptiometry (DXA)

Standard Operating Procedure TCRC Dual-Energy X-ray Absorptiometry (DXA) 1. RELEVANCE a. This SOP outlines the instructions to completing Duel Energy X-Ray Absorptiometry (DXA) including: scanning, analysis, review and filing. 2. SCOPE a. This SOP applies to all TCRC RDs. 3.

More information

LUMBAR IS IT IMPORTANT? S. Tantawy,, M.D.

LUMBAR IS IT IMPORTANT? S. Tantawy,, M.D. بسم االله الرحمن الرحيم DEXA LATERAL LUMBAR IS IT IMPORTANT? By S. Tantawy,, M.D. Osteopenia,, bone mineral deficiency in the absence of fracture, is an indicator of the bone structural integrity and compared

More information

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,

More information

INFORMATION for PATIENTS

INFORMATION for PATIENTS INFORMATION for PATIENTS What is MRI? Magnetic Resonance Imaging uses a computer, magnetic fields and radio waves to generate images of the body. It can be used for virtually all parts of the body, generating

More information

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one

More information

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.

More information

Healthy aging. It s vital.

Healthy aging. It s vital. GE Healthcare Healthy aging. It s vital. encore 17 The leading edge of DXA applications This trio of new encore 17 functions will take your clinical assessment capability to the next level. We are pleased

More information

Measuring Bone Mass among Uninsured Hispanic Women with Quantitative Ultrasound. A Thesis Presented in Partial Fulfillment of the Application for

Measuring Bone Mass among Uninsured Hispanic Women with Quantitative Ultrasound. A Thesis Presented in Partial Fulfillment of the Application for Measuring Bone Mass among Uninsured Hispanic Women with Quantitative Ultrasound A Thesis Presented in Partial Fulfillment of the Application for Graduation with Distinction in Radiologic Sciences and Therapy

More information

MRI assessment of vertebral fractures identified by conventional radiography in osteoporotic patients: a preliminary study

MRI assessment of vertebral fractures identified by conventional radiography in osteoporotic patients: a preliminary study MRI assessment of vertebral fractures identified by conventional radiography in osteoporotic patients: a preliminary study Poster No.: C-1405 Congress: ECR 2013 Type: Scientific Exhibit Authors: R. Argirò,

More information

Advanced Point-of-Care Bone Health Assessment HOLOGIC OSTEOPOROSIS ASSESSMENT

Advanced Point-of-Care Bone Health Assessment HOLOGIC OSTEOPOROSIS ASSESSMENT O S T E O P O R O S I S A S S E S S M E N T Advanced Point-of-Care Bone Health Assessment HOLOGIC OSTEOPOROSIS ASSESSMENT Identify Patients at Risk The evaluation of bone health has become an essential

More information

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

QDR Series. Discovery and Explorer Advanced Health Assessment

QDR Series. Discovery and Explorer Advanced Health Assessment O S T E O P O R O S I S A S S E S S M E N T QDR Series Discovery and Explorer Advanced Health The Hologic QDR Series bone densitometers combine the proven clinical value of bone mineral density (BMD) measurement

More information

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada Jacques P. Brown, Robert G. Josse, for the Scientific Advisory Council of the Osteoporosis Society of Canada

More information

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017 Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Based on review of available data, the Company may consider the use of denosumab (Prolia) for the

Based on review of available data, the Company may consider the use of denosumab (Prolia) for the Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Summary HTA. HTA-Report Summary

Summary HTA. HTA-Report Summary Summary HTA HTA-Report Summary Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events Schnell-Inderst

More information

Clinical Application of Computed Radiography in Orthopedic Surgery

Clinical Application of Computed Radiography in Orthopedic Surgery Clinical Application of Computed Radiography in Orthopedic Surgery Satoru Fujita, Masamichi Tanaka, Sigeaki Hirota, and Takeshi Fuji Since 1988, Fuji Computed Radiography (FCR) system (Fuji Medical Systems,

More information

HTA. Diagnostic Performance and Cost-Effectiveness of Technologies to Measure Bone Mineral Density in Postmenopausal Women

HTA. Diagnostic Performance and Cost-Effectiveness of Technologies to Measure Bone Mineral Density in Postmenopausal Women Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé t e c h n o l o g y r e p o r t HTA Issue 94 December 2007 Diagnostic Performance

More information

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits

More information

Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen

Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen Christian Muschitz II. Medizinische Abteilung mit Rheumatologie, Osteologie & Gastroenterologie Akademisches Lehrkrankenhaus

More information

Bone Densitometry Radiation dose: what you need to know

Bone Densitometry Radiation dose: what you need to know Bone Densitometry Radiation dose: what you need to know John Damilakis, PhD Associate Professor and Chairman University of Crete, Iraklion, Crete, GREECE Estimation of bone status using X-rays Assessment

More information

Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems?

Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? Osteoporos Int (2010) 21:1227 1236 DOI 10.1007/s00198-009-1062-3 ORIGINAL ARTICLE Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? B. Fan & Y. Lu

More information

Portfolio Requirements and Instructions 2018

Portfolio Requirements and Instructions 2018 Portfolio Requirements and Instructions 2018 Introduction The purpose of the portfolio is to demonstrate your understanding and practical ability in bone densitometry across four sections. It is to provide

More information

Top: Healthy Vertebrae Above: Osteoporotic bone

Top: Healthy Vertebrae Above: Osteoporotic bone Top: Healthy Vertebrae Above: Osteoporotic bone 2 OSTEOPOROSIS IS A DISEASE OF THE BONES, WHICH LEADS TO AN INCREASED RISK OF FRACTURE. IN OSTEOPOROSIS, THE DENSITY AND QUALITY OF BONE ARE REDUCED. THE

More information

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Use of DXA / Bone Density in the Care of Your Patients Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Important Websites Resources for Clinicians and Patients www.nof.org www.iofbonehealth.org

More information

Submission to the National Institute for Clinical Excellence on

Submission to the National Institute for Clinical Excellence on Submission to the National Institute for Clinical Excellence on Strontium ranelate for the prevention of osteoporotic fractures in postmenopausal women with osteoporosis by The Society for Endocrinology

More information

Management of postmenopausal osteoporosis

Management of postmenopausal osteoporosis Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,

More information

Annotations Part III Vertebral Fracture Initiative. International Osteoporosis Foundation March 2011

Annotations Part III Vertebral Fracture Initiative. International Osteoporosis Foundation March 2011 Annotations Part III Vertebral Fracture Initiative International Osteoporosis Foundation March 2011 Slide 1-3 Topics to be covered: What is vertebral fracture assessment? How does VFA compare to standard

More information

Sponsor / Company: sanofi-aventis and Proctor & Gamble Drug substance(s): Risedronate (HMR4003)

Sponsor / Company: sanofi-aventis and Proctor & Gamble Drug substance(s): Risedronate (HMR4003) These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: sanofi-aventis and

More information

BIOSTATISTICAL METHODS

BIOSTATISTICAL METHODS BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH PROPENSITY SCORE Confounding Definition: A situation in which the effect or association between an exposure (a predictor or risk factor) and

More information

Trabecular bone analysis with tomosynthesis in diabetic patients: comparison with CT-based finite-element method

Trabecular bone analysis with tomosynthesis in diabetic patients: comparison with CT-based finite-element method Trabecular bone analysis with tomosynthesis in diabetic patients: comparison with CT-based finite-element method Poster No.: C-1789 Congress: ECR 2015 Type: Scientific Exhibit Authors: M. Fujii, T. Aoki,

More information

Live Educational Programs

Live Educational Programs Live Educational Programs 2014 Osteoporosis: Essentials of Densitometry, Diagnosis and Management - for Clinicians Osteoporosis: Essentials of Densitometry, Diagnosis and Management - for Technologists

More information

Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv. Chapter 1: Densitometry Techniques...

Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv. Chapter 1: Densitometry Techniques... CONTENTS Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv Chapter 1: Densitometry Techniques... 1 Plain Radiography in the Assessment of Bone Density...

More information

Introducing the future of DXA. Powerful images. Clear answers. Horizon DXA System

Introducing the future of DXA. Powerful images. Clear answers. Horizon DXA System Introducing the future of DXA Powerful images. Clear answers. Horizon DXA System Hologic turns ideas into innovation. Again. Hologic cares about you and your patients about keeping their bones healthy,

More information

New Ultrasound System for Bone Assessment

New Ultrasound System for Bone Assessment New Ultrasound System for Bone Assessment Jonathan J. Kaufman a,b, Gangming Luo c, David Conroy d, William A. Johnson e, Ronald L. Altman e, Robert S. Siffert b a CyberLogic, Inc., 611 Broadway, Suite

More information

2013 ISCD Combined Official Positions

2013 ISCD Combined Official Positions 2013 ISCD Combined Oicial Positions Oicial Positions of the International Society for Clinical Densitometry The International Society for Clinical Densitometry (ISCD) is a not-for-profit multidisciplinary

More information

Bone density scanning and osteoporosis

Bone density scanning and osteoporosis Bone density scanning and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break

More information

Coordinator of Post Professional Programs Texas Woman's University 1

Coordinator of Post Professional Programs Texas Woman's University 1 OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic

More information

This is a repository copy of Microarchitecture of bone predicts fractures in older women.

This is a repository copy of Microarchitecture of bone predicts fractures in older women. This is a repository copy of Microarchitecture of bone predicts fractures in older women. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/130351/ Version: Accepted Version

More information

Clinical Specialist Statement Template

Clinical Specialist Statement Template Clinical Specialist Statement Template Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can

More information

Advanced DXA Using TBS insight

Advanced DXA Using TBS insight Advanced DXA Using TBS insight A New Bone Structure Assessment Technique Enhances Identification of Fracture Risk Introduction The World Health Organization defines osteoporosis as asilent disease characterised

More information

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry R Gilles, Laurentius Ziekenhuis Roermond 1. Introduction Osteoporosis is characterised by low bone mass, disruption of the micro-architecture

More information

Osteoporosis: Who, What, When, Why, and How

Osteoporosis: Who, What, When, Why, and How Osteoporosis: Who, What, When, Why, and How Doris J. Uh, PharmD, AE-C Pharm 445 September 20, 2005 Objectives define osteoporosis (what) determine high risk groups (who, when) review modifiable, non-modifiable

More information

An audit of osteoporotic patients in an Australian general practice

An audit of osteoporotic patients in an Australian general practice professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to

More information

The prevalence and history of knee osteoarthritis in general practice: a case control study

The prevalence and history of knee osteoarthritis in general practice: a case control study The Author (2005). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org doi:10.1093/fampra/cmh700 Family Practice Advance Access

More information

User's Guide. Document No Revision D

User's Guide. Document No Revision D User's Guide Document No. 080-0631 Revision D January, 1998 The information contained in this Manual is confidential and proprietary to Hologic, Inc. This information is provided only to authorized representatives

More information

Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women

Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women Osteoporos Int (2011) 22:2365 2371 DOI 10.1007/s00198-010-1452-6 ORIGINAL ARTICLE Prevalence of vertebral fractures on chest radiographs of elderly African American and Caucasian women D. Lansdown & B.

More information

Densitometry Techniques

Densitometry Techniques 2 Densitometry Techniques CONTENTS PLAIN RADIOGRAPHY IN THE ASSESSMENT OF BONE DENSITY QUALITATIVE MORPHOMETRY QUALITATIVE SPINAL MORPHOMETRY THE SINGH INDEX QUANTITATIVE MORPHOMETRIC TECHNIQUES CALCAR

More information

Name of Policy: Boniva (Ibandronate Sodium) Infusion

Name of Policy: Boniva (Ibandronate Sodium) Infusion Name of Policy: Boniva (Ibandronate Sodium) Infusion Policy #: 266 Latest Review Date: April 2010 Category: Pharmacology Policy Grade: Active Policy but no longer scheduled for regular literature reviews

More information

Bone Densitometry. Total 30 Maximum CE 14. DXA Scanning (10) 7

Bone Densitometry. Total 30 Maximum CE 14. DXA Scanning (10) 7 STRUCTURED SELF ASSESSMENT CONTENT SPECIFICATIONS SSA LAUNCH DATE: JANUARY 1, 2018 Bone Densitometry The purpose of continuing qualifications requirements (CQR) is to assist registered technologists in

More information

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Prevalence and Probability of Diabetes in Patients Referred for Stress Testing in Northeast

More information

Prodigy. from GE Healthcare. Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world. gehealthcare.

Prodigy. from GE Healthcare. Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world. gehealthcare. Prodigy from GE Healthcare Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world gehealthcare.com Prodigy High performance, efficient and reliable DXA system

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/28958 holds various files of this Leiden University dissertation Author: Keurentjes, Johan Christiaan Title: Predictors of clinical outcome in total hip

More information

CLINIQCT NO-DOSE CT BONE DENSITOMETRY FOR ROUTINE AND SPECIALIST USE.

CLINIQCT NO-DOSE CT BONE DENSITOMETRY FOR ROUTINE AND SPECIALIST USE. CLINIQCT NO-DOSE CT BONE DENSITOMETRY FOR ROUTINE AND SPECIALIST USE Clinically superior BMD solutions for physicians DXA equivalent hip measurements Dual-use of standard abdominal or pelvic CT studies

More information

Unit 1 Exploring and Understanding Data

Unit 1 Exploring and Understanding Data Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile

More information

Ghada El-Hajj Fuleihan, MD,MPH.

Ghada El-Hajj Fuleihan, MD,MPH. Ghada El-Hajj Fuleihan, MD,MPH. Dr El-Hajj Fuleihan is Professor of Medicine and Founder and Director of the Calcium Metabolism and Osteoporosis Program at the American University of Beirut Medical Center.

More information

The Bone Densitometry Examination

The Bone Densitometry Examination The Bone Densitometry Examination The purpose of The American Registry of Radiologic Technologist (ARRT ) Bone Densitometry Examination is to assess the knowledge and cognitive skills underlying the intelligent

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int (2007) 18:1033 1046 DOI 10.1007/s00198-007-0343-y ORIGINAL ARTICLE The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in

More information

Evaluation of Bone Mineral Status in Adolescent Idiopathic Scoliosis

Evaluation of Bone Mineral Status in Adolescent Idiopathic Scoliosis Original Article Clinics in Orthopedic Surgery 2014;6:180-184 http://dx.doi.org/10.4055/cios.2014.6.2.180 Evaluation of Bone Mineral Status in Adolescent Idiopathic Scoliosis Babak Pourabbas Tahvildari,

More information

Comparison of Two Bone Mineral Density Pre- Screening Tools: Qus and Ra, to the Dxa

Comparison of Two Bone Mineral Density Pre- Screening Tools: Qus and Ra, to the Dxa Georgia Southern University Digital Commons@Georgia Southern Electronic Theses & Dissertations COGS- Jack N. Averitt College of Graduate Studies Spring 2010 Comparison of Two Bone Mineral Density Pre-

More information

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1 Date: 21 November 2016 Page 1 2. SYNOPSIS Name of Sponsor: Amgen Inc., Thousand Oaks, CA, USA Name of Finished Product: Prolia Name of Active Ingredient: denosumab Title of Study: Randomized, Double-blind,

More information

University of Groningen. Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert

University of Groningen. Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert University of Groningen Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.

Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Principal Investigator: Dick Menzies, MD Evidence base for treatment of INH resistant

More information

Outline Vertebroplasty and Kyphoplasty: Who, What, and When

Outline Vertebroplasty and Kyphoplasty: Who, What, and When Outline Vertebroplasty and Kyphoplasty: Who, What, and When Douglas C. Bauer, MD University of California San Francisco, USA Vertebral fracture epidemiology, consequences and diagnosis Kyphoplasty and

More information

Osteoporosis Screening and Treatment in Type 2 Diabetes

Osteoporosis Screening and Treatment in Type 2 Diabetes Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information

More information

Building Bone Density-Research Issues

Building Bone Density-Research Issues Building Bone Density-Research Issues Helping to Regain Bone Density QUESTION 1 What are the symptoms of Osteoporosis? Who is at risk? Symptoms Bone Fractures Osteoporosis 1,500,000 fractures a year Kyphosis

More information

May Professor Matt Stevenson School of Health and Related Research, University of Sheffield

May Professor Matt Stevenson School of Health and Related Research, University of Sheffield ASSESSING THE FEASIBILITY OF TRANSFORMING THE RECOMMENDATIONS IN TA160, TA161 AND TA204 INTO ABSOLUTE 10-YEAR RISK OF FRACTURE A REPORT PRODUCED BY THE DECISION SUPPORT UNIT IN THE CONTEXT OF THE REVIEW

More information